CoChat

Changes in the Expression of Many Ets Family Transcription Factors and of Potential Target Genes in Normal Mammary Tissue and Tumors

Open access

The DOI matches its Crossref record; 74 of the 75 references it cites were found in a registry or an index.

Abstract

Interfering with Ets transcription factor function reverses multiple aspects of the transformed phenotype of mouse or human tumor cells. However, the unknown number of individual Ets factors expressed in any cellular context and the similar DNA binding specificities of Ets family members complicates the identification of those that mediate transformation. By utilizing quantitative PCR assays for 25 mouse Ets factors, we analyzed the expression of essentially the entire Ets family in normal mammary tissue, mammary-related cell lines, and mammary tumors. In normal mammary tissue, 24 Ets factors were expressed. Even clonal derived cell lines expressed 14-20 Ets members. The most abundant Ets factor mRNAs measured in normal mammary tissue were Elk4, Elf1, and Ets2. Subtractive analysis of mammary tissue identified which Ets factors were predominantly expressed in the myeloid/lymphoid or epithelial cell compartments. Comparison of Ets factor expression in normal mammary tissue and mammary tumors identified significantly elevated expression of Pse/PDEF, Ese2/Elf5, Ese3/Ehf, TEL/Etv6, and Elf2/NERF in mammary tumors and confirmed previously reported alterations in expression of Ese1/Elf3 and the PEA3 subfamily. Expression of 13 Ets target genes, implicated in various aspects of tumor progression, was also analyzed. Altered expression of particular Ets target genes was significantly correlated with particular Ets factors (e.g. maspin and Ese2), suggesting specific in vivo regulatory roles. Together, this comprehensive analysis revealed unexpectedly diverse Ets family gene expression, characterized novel Ets factor changes in mammary tumors, and implicated specific Ets factors in the regulation of multiple genes involved in mammary tumor progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m311887200

Cites

74 of 75 references verified0 citation errors · 1 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 75 references

Research works printed but not linked: 15

  1. 5. Dittmer, J. ∙ Nordheim, A. Biochim. Biophys. Acta. 1998; 1377:F1-F11 PubMed Google Scholar
  2. 8. Langer, S.J. ∙ Bortner, D.M. ∙ Roussel, M.F. ... Mol. Cell. Biol. 1992; 12:5355-5362 Crossref Scopus (147) PubMed Google Scholar
  3. 11. de Nigris, F. ∙ Mega, T. ∙ Berger, N. ... Cancer Res. 2001; 61:2267-2275 PubMed Google Scholar
  4. 12. Sapi, E. ∙ Flick, M.B. ∙ Rodov, S. ... Cancer Res. 1998; 58:1027-1033 PubMed Google Scholar
  5. 17. Neznanov, N. ∙ Man, A.K. ∙ Yamamoto, H. ... Cancer Res. 1999; 59:4242-4246 PubMed Google Scholar
  6. 18. Trimble, M.S. ∙ Xin, J.H. ∙ Guy, C.T. ... Oncogene. 1993; 8:3037-3042 PubMed Google Scholar
  7. 22. Andrechek, E.R. ∙ Laing, M.A. ∙ Girgis-Gabardo, A.A. ... Cancer Res. 2003; 63:4920-4926 PubMed Google Scholar
  8. 24. Ghadersohi, A. ∙ Sood, A.K. Clin. Cancer Res. 2001; 7:2731-2738 PubMed Google Scholar
  9. 27. Boyd, K.E. ∙ Farnham, P.J. Proc. Soc. Exp. Biol. Med. 1999; 222:9-28 Crossref Scopus (36) PubMed Google Scholar
  10. 36. Guy, C.T. ∙ Cardiff, R.D. ∙ Muller, W.J. Mol. Cell. Biol. 1992; 12:954-961 Crossref Scopus (1346) PubMed Google Scholar
  11. 41. Rozen, S. ∙ Skaletsky, H.J. Krawetz, S. ∙ Misener, S. (Editors) Bioinformatics Methods and Protocols: Methods in Molecular Biology Humana Press, Totowa, NJ, 2000; 365-386 Google Scholar
  12. 56. Chen, J.H. ∙ Vercamer, C. ∙ Li, Z. ... Oncogene. 1996; 13:1667-1675 PubMed Google Scholar
  13. 57. Zhang, M. ∙ Maass, N. ∙ Magit, D. ... Cell Growth Differ. 1997; 8:179-186 PubMed Google Scholar
  14. 64. Feldman, R.J. ∙ Sementchenko, V.I. ∙ Gayed, M. ... Cancer Res. 2003; 63:4626-4631 PubMed Google Scholar
  15. 70. Nozawa, M. ∙ Yomogida, K. ∙ Kanno, N. ... Cancer Res. 2000; 60:1348-1352 PubMed Google Scholar

Cited by

Metadata

Authors
Galang, C. K., Muller, W. J., Foos, G., Oshima, R. G., & Hauser, C. A.
Affiliations
  • Sanford Burnham Prebys Medical Discovery Institute (US)
  • McGill University (CA)
Corresponding author
Hauser, Craig A.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2004-03
Volume
279
Issue
12
Pages
11281-11292
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2087260415
Cited by
132
References
74
Citations by year
2025: 2 · 2024: 3 · 2023: 4 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 5 · 2016: 4 · 2015: 5 · 2014: 7 · 2013: 10 · 2012: 7
FWCI
4.75
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • TSpace (University of Toronto) (submittedVersion)
Funders
  • National Institutes of Health (5r01ca063130-07)
  • National Cancer Institute (R01CA074547, CA30199, CA74547, CA63130, P30CA030199)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
ETS transcription factors, mammary tumors, mammary gland, gene expression profiling, maspin, mammary tumor progression
MeSH terms
Animals, Cell Line, DNA-Binding Proteins, Gene Expression Regulation, Mammary Glands, Animal, Mammary Neoplasms, Experimental, Transcription Factors, Polymerase Chain Reaction, DNA, Complementary, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.